Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

MMWR Recomm Rep. 1996 May 3;45(RR-5):1-24.

Abstract

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1996-97 influenza season (superseding MMWR 1995;44(No. RR-3):1-22). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1996-97 and b) extension of the optimal time for influenza vaccination campaigns for persons in high-risk groups.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amantadine / adverse effects
  • Amantadine / therapeutic use
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Contraindications
  • Drug Interactions
  • Female
  • Humans
  • Immunization Programs
  • Immunization Schedule
  • Infant
  • Infection Control / standards
  • Influenza A virus / immunology*
  • Influenza B virus / immunology*
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / adverse effects
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Middle Aged
  • Pregnancy
  • Rimantadine / adverse effects
  • Rimantadine / therapeutic use
  • Risk Factors
  • United States
  • Vaccination / adverse effects
  • Vaccination / standards*
  • Vaccines, Inactivated / administration & dosage*
  • Vaccines, Inactivated / adverse effects

Substances

  • Antiviral Agents
  • Influenza Vaccines
  • Vaccines, Inactivated
  • Rimantadine
  • Amantadine